RD Lewis Holdings Inc. Makes New $5.06 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

RD Lewis Holdings Inc. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 8,515 shares of the biotechnology company's stock, valued at approximately $5,061,000. Axon Enterprise comprises about 5.8% of RD Lewis Holdings Inc.'s portfolio, making the stock its biggest holding.

Several other institutional investors have also added to or reduced their stakes in the company. Asset Dedication LLC lifted its stake in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 18 shares during the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC increased its stake in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC raised its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after acquiring an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC lifted its holdings in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after purchasing an additional 24 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC restated a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $604.67.

Axon Enterprise Stock Up 0.3 %

Shares of NASDAQ AXON traded up $1.59 during mid-day trading on Friday, reaching $560.00. 802,214 shares of the company's stock traded hands, compared to its average volume of 845,276. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50-day simple moving average of $592.10 and a 200 day simple moving average of $539.60. The stock has a market cap of $42.91 billion, a P/E ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business's stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,792 shares of company stock valued at $1,087,843 over the last ninety days. 5.70% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.